Product Information

HYDROMORPHONE HCL ER 12 MG TAB is a generic product labeled by Trigen Laboratories, LLC, priced at $10.2571 per EA under NDC 13811070210. Its NADAC has been published 276 times since Jan 11, 2017.

FDA first approved this application on Jul 7, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the Hydromorphone Hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

HYDROMORPHONE HCL ER 12 MG TAB

Hydromorphone Hydrochloride
$10.2571per EA
High Outlier
DEA Schedule CII

Strength

12 mg/1

NDC

13811070210

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

HYDROMORPHONE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA205629

FDA Approved

7/7/2016

TE Code

AB

On Market Since

9/15/2016

Pharmacological Classes

Full Opioid Agonists
Opioid Agonist

Price Statistics

The NADAC for HYDROMORPHONE HCL ER 12 MG TAB has been published 276 times since Jan 11, 2017, and over the history we have for it it has declined 25.4%. The table below summarizes its recorded NADAC range and movement.

Current price$10.2571 per EA
All-time high$13.7450 (Apr 12, 2017)
All-time low$6.6999 (Nov 20, 2024)
52-week high$10.5411
52-week low$8.6407
Median price$9.2797
Average price$9.7348
Largest weekly change+26.4% (Nov 21, 2018)
Weeks tracked276
Tracking sinceJan 11, 2017

Price History

1W

+0.7%

1M

+0.7%

3M

+4.4%

6M

+18.7%

1Y

-2.7%

3Y

+11.3%

5Y

+11.3%

All

-25.4%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Hydromorphone Hydrochloride market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of HYDROMORPHONE HCL ER 12 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for HYDROMORPHONE HCL ER 12 MG TAB, manufactured by Trigen Laboratories, LLC, is $10.2571 per EA (NDC 13811070210), effective Aug 19, 2026.

How has the price of HYDROMORPHONE HCL ER 12 MG TAB changed over time?

Over the history we have for it, the NADAC for HYDROMORPHONE HCL ER 12 MG TAB has declined 25.4%. It has been tracked across 276 weekly CMS publications since Jan 11, 2017.

What are the highest and lowest recorded NADAC prices for HYDROMORPHONE HCL ER 12 MG TAB?

Since Jan 11, 2017, the NADAC for HYDROMORPHONE HCL ER 12 MG TAB has ranged from a low of $6.6999 (Nov 20, 2024) to a high of $13.7450 (Apr 12, 2017), with a median of $9.2797 per EA.

Are there cheaper alternatives to HYDROMORPHONE HCL ER 12 MG TAB?

No other NADAC-published product currently shares the active ingredient and strength of HYDROMORPHONE HCL ER 12 MG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures HYDROMORPHONE HCL ER 12 MG TAB?

HYDROMORPHONE HCL ER 12 MG TAB (NDC 13811070210) is labeled by Trigen Laboratories, LLC, and CMS classifies it as a generic product.